![Russia skyline.](/mediaassets/images/corporate/careers/our-locations/copy-of-russia-skyline.jpg?w=1920&la=en-GB&focalpointcrop=1&xratio=0&yratio=0&hash=7A7CA2EFD98F7DA0099F1815AC4DD221)
Russia
We are no longer operating in Russia. In 2021, less than 1% of Group sales were to Russia.
We remain hopeful that a peaceful resolution to the conflict can be found.
Further reading
![](/mediaassets/images/corporate/news/dsc00581.jpg?w=768&la=en-GB&focalpointcrop=1&xratio=0&yratio=0&hash=643B87E09825A7A47016A19D54479CFF)
Completed divestment – transitioning to a pure-play Consumer Care and Life Sciences company
Accelerating our transition to a pure-play Consumer Care and Life Sciences company, completion of the divestment of the majority of our Performance Technologies and Industrial Chemicals businesses to...
![Danuta Gray](/mediaassets/images/corporate/news/danuta-gray.jpg?w=768&la=en-GB&focalpointcrop=1&xratio=0&yratio=0&hash=4E48F0E0B0E04194C80E110FED527420)
Appointment of Chair Designate
22 September 2023: We are pleased to announce the appointment of Danuta Gray as a Non-Executive Director and Chair Designate
![](/mediaassets/images/corporate/innovation/biotech-png.jpg?w=768&la=en-GB&focalpointcrop=1&xratio=0&yratio=0&hash=D425B49E1AF072D0F69EC54CA552A453)
Launch of first report on biotechnology opportunities in the personal care market
27 September 2022: The “Biotechnology: personal care market report” is the first in a series from Croda which aim to help other forward-thinking companies leverage the opportunities offered by...
![Laboratory work](/mediaassets/images/corporate/shutterstock-1431826262.jpg?w=768&la=en-GB&focalpointcrop=1&xratio=0&yratio=0&hash=7BA9F7A82C598C9588A2A8A19234BDAA)
UK Government to support expansion of Croda's lipid systems manufacturing facility
31 March 2022: This investment will significantly enhance the development of high-purity lipid systems, essential delivery systems for next generation nucleic acid drugs such as mRNA vaccines.